Effective August 1, 2025, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) is implementing a new Genetic and Molecular Testing reimbursement policy.
Blue Cross NC will implement guidelines set forth by industry authorities in the reimbursement of genetic testing in accordance with best practice standards, which are detailed within the policy. Please see the related policy notification for more information.
Blue Cross NC is making this change to ensure accurate and consistent coding and reimbursement for genetic testing services.
This new policy will apply to Commercial, Inter-Plan Program (IPP) Host, and Federal Employee Program (FEP). This will not apply to IPP Home and Medicare Advantage.
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.